div
Latest News For Cancer / Oncology
Bristol-Myers Squibb And PDL BioPharma Enter Global Alliance To Develop Novel Treatment For Multiple Myeloma
21 Aug 2008
Researcher Aims To 'Unmask' Cancer Cells To Trigger Body's Immune System
21 Aug 2008
New Insights Into The Regulation Of PTEN Tumor Suppressor Function
21 Aug 2008
View more news...
Latest Videos for Cancer
Monitoring and Adherence in CML
Imatinib, or Gleevec, is a targeted antitumour drug that can retain chronic myelogenous leukemia (CML) in
